Health news from UAB

By mapping a patient’s genome, and their tumor’s, with whole-genome sequencing, physicians can use more targeted therapies.

Adding cystatin C to a diagnostic panel revealed one person in six who had chronic kidney disease that was undetected using the conventional test.

The UAB Center for Exercise Medicine studies what type of exercise, and how much, is best for people with hypertension, cancer and more.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

Cosmic radiation could be problematic for future astronauts’ arteries, but research could soon inform care for Earth-bound cancer patients.
«PrevNext»
Page 43 of 55